Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 7Active not recruiting 5Completed 3Unknown 1

Sponsor Class

OTHER 5

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 846Carcinoma, Non-Small-Cell Lung 553Neoplasms 516Prostatic Neoplasms 503Lung Neoplasms 312Colorectal Neoplasms 304Multiple Myeloma 295Neoplasm Metastasis 255Melanoma 244Ovarian Neoplasms 215Leukemia, Myeloid, Acute 212Pancreatic Neoplasms 203Squamous Cell Carcinoma of Head and Neck 171Carcinoma, Renal Cell 166Stomach Neoplasms 160Recurrence 159Lymphoma 159Carcinoma, Hepatocellular 159Glioblastoma 151Brain Neoplasms 151Lymphoma, Non-Hodgkin 143Uterine Cervical Neoplasms 142Head and Neck Neoplasms 141Urinary Bladder Neoplasms 137Leukemia, Lymphocytic, Chronic, B-Cell 137Triple Negative Breast Neoplasms 136Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Hematologic Neoplasms 117Colonic Neoplasms 117Lymphoma, Follicular 114

Interventions

pyrotinib 1pertuzumab 1Trastuzumab 1Surgical Procedures, Operative 1Neoadjuvant Therapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Breast Cancer Invasive × Clear all
NCT07590570 2026-05-15

The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer

RenJi Hospital

Active not recruiting
188 enrolled
Breast

Breast Cancer Invasive

NCT07283718 2026-05-13

The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis

RenJi Hospital

Active not recruiting
2,467 enrolled
Breast

Breast Cancer Invasive

NCT07584213 2026-05-13

The Association Between Blood Routine Parameters and Breast Cancer Prognosis

RenJi Hospital

Active not recruiting
2,946 enrolled
Breast

Breast Cancer Invasive

NCT06583655 2025-07-31

Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer

Ruijin Hospital

Phase NA Active not recruiting
205 enrolled
Breast

Breast Cancer Invasive

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Shanghai Jiao Tong University School of Medicine

Phase 2 Active not recruiting
216 enrolled
Breast

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡